These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 2204124)
1. [Interferon and chronic myeloid leukemia]. Steegmann JL; Pérez Sánchez M; Fernández-Rañada JM Sangre (Barc); 1990 Jun; 35(3):213-7. PubMed ID: 2204124 [No Abstract] [Full Text] [Related]
2. Chronic myeloid leukemia. A perspective of the clinical and biologic issues of the chronic phase. Silver RT Hematol Oncol Clin North Am; 1990 Apr; 4(2):319-35. PubMed ID: 2182594 [TBL] [Abstract][Full Text] [Related]
3. [Chronic myeloid leukemia: progress and prospects]. Baccarani M; Russo D; Fanin R Haematologica; 1991 Jun; 76 Suppl 3():40-5. PubMed ID: 1752539 [No Abstract] [Full Text] [Related]
9. Treatment of chronic granulocytic leukemia in blastic crisis. Canellos GP Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():131-2. PubMed ID: 2565744 [No Abstract] [Full Text] [Related]
10. Interferon induced cytogenetic improvement in CGL patients in haematological relapse post allograft. Aitchison R; Collins P; Newland AC Bone Marrow Transplant; 1990 Dec; 6(6):453. PubMed ID: 2097016 [No Abstract] [Full Text] [Related]
11. Interferon alfa has become a standard in the treatment of chronic myelogenous leukemia. Freund M; Huber C Semin Hematol; 1993 Jul; 30(3 Suppl 3):1-5. PubMed ID: 8235694 [No Abstract] [Full Text] [Related]
17. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia. Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725 [TBL] [Abstract][Full Text] [Related]
18. Clinical value of quantitative long-term assessment of bcr-abl chimeric transcript in chronic myelogenous leukemia patients after allogeneic bone marrow transplantation. Martinelli G; Montefusco V; Testoni N; Amabile M; Saglio G; Ottaviani E; Terragna C; Bonifazi F; Rosti G; Bandini G; Tura S Haematologica; 2000 Jun; 85(6):653-8. PubMed ID: 10870124 [TBL] [Abstract][Full Text] [Related]
19. [Molecular biology follow-up of interferon therapy in patients with chronic myeloid leukemia]. Iványi JL; Marton E; Kereskai L; Kiss Z; Pajor L Orv Hetil; 2000 Nov; 141(47):2527-33. PubMed ID: 11143285 [TBL] [Abstract][Full Text] [Related]
20. Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia. Heimpel H; Allan NC; Baccarani M; Guilhot F; Hehlmann R; Horowitz M; Kluin-Nelemans J; Schaefer U; Storb R; Thaler J Bone Marrow Transplant; 1996 May; 17 Suppl 3():S39. PubMed ID: 8769699 [No Abstract] [Full Text] [Related] [Next] [New Search]